BCS 2013

Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk

By

Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.

Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women

By

A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.

Perioperative MRI of Uncertain Benefit for Women with DCIS

By

The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.

Dr. Edith Perez's Recommended Abstracts at BCS 2013

Dr. Edith Perez's Recommended Abstracts at BCS 2013

By

ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.

Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease

By

Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.

Patient Advocates Help Identify Patient-Reported Outcomes for Research

By

Workshops with patient advocates are a promising approach to identifying meaningful patient-reported outcome end points for clinical studies of breast cancer treatments, found research at BCS 2013.

Eribulin Outcomes 'Comparable' Regardless of Triple-Negative Status, Prior Anthracyclines

By

Eribulin safety and time to treatment failure in real-world clinical settings are comparable to those identified in previous clinical trials, found a study presented at BCS 2013.

T-DM1 for Metastatic Breast Cancer is Safe, Effective in Clinical Setting

By

T-DM1 is as safe and effective in previously treated patients with HER2+ metastatic breast cancer in clinical settings as it was in clinical trials, found research at BCS 2013.

Patients Prioritize Recurrence Assessment, Psychological Support at Post-Treatment Appointments

By

Most patients would prefer to receive assessments, support during follow-up appoints, but details of their preferences after treatment vary, found data presented at BCS 2013.

Premenopausal Status Associated with Weight Gain During Breast Cancer Chemotherapy

By

Weight gain during chemotherapy is associated with premenopausal status but not patient age, tumor histology or stage, or therapeutic regimens, found research at BCS 2013.

Breast Cancer Survivors Prefer Webinars for Post-Treatment Education

By

Survivors of breast cancer prefer a one-on-one consultation with a clinician followed by topic-specific online webinars that include live Q&A sessions, found research presented at BCS 2013.

Two Major Dysregulated Functions Identified in Inflammatory Breast Cancer

By

Genome-wide microarray analyses of copy number variation and gene expression found two dysregulated functions in inflammatory breast cancer, found a study at BCS 2013.

dtectDx™ Breast Assay Plus Standard of Care Improves Breast Cancer Detection in Women Younger than 50

By

Combined with standard of care, the dtectDx Breast test is most effective at detecting breast cancer in women age 50 or younger, found data presented at BCS 2013.

Bioelectrical Impedance Analysis May Reliably Detect Lymphedema in Breast Cancer Survivors

By

Bioelectrical impedance analysis misses 20% of true lymphedema cases, but was reliable in survivors with lymphedema, according to data presented at BCS 2013.

'Taking Control of Cancer' Ups Rates of Unilateral, Contralateral Prophylactic Mastectomies

By

Women who underwent unilateral or contralateral prophylactic mastectomy instead of breast-conserving surgery felt they were "taking control of cancer", found research presented at BCS 2013.

Classic Lobular Carcinoma Characterized by Differential Patterns of Gene Expression

By

Ductal not otherwise specified carcinomas account for 81.8% of ER-positive breast cancer cases, found a study presented at BCS 2013.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs